Kyle Smith has been named President and Chief Operating Officer of Aprecia Pharmaceuticals, LLC, responsible for leading day-to-day business activities. Mr. Smith is a 10-year veteran with Aprecia and has served as Vice President of Operations for the past three years.
 
Aprecia also strengthened its leadership team with the promotion of Patrick Staudt to Vice President of Operations. A 14-year veteran of Aprecia, Mr. Staudt has led the East Windsor, NJ manufacturing operations for more than 10 years and will lead expected, expansive growth through multiple technology platforms.
 
Mr. Smith and Mr. Staudt have been cornerstones of Aprecia’s history of technology and manufacturing innovation. They have been key contributors in establishing the company as a leader in the development and manufacturing of pharmaceutical products through 3D-Printing. Their experiences with Aprecia have helped craft the company culture and 3DP pharmaceutical manufacturing innovation, and their contributions have created a momentum which continues to accelerate through important partnerships and novel products.  
 
“As Aprecia’s technology platforms expand and industry partnerships advance, Aprecia requires additional talent and resources to meet these growing demands,” said Chris Gilmore, Aprecia’s Chief Executive Officer. “We are fortunate to have these seasoned technology experts and corporate leaders to promote and guide the organizational growth well into the future.”